CASTLE BIOSCIENCES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $39.00K.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2020-12-31 was $250.16M.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $10.42M, a 84.19% decline year-over-year.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $69.08M.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2021 was $39.00K, a 99.99% decline from fiscal 2020.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2020 was $329.66M, a 400.01% increase from fiscal 2019.
- CASTLE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2019 was $65.93M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $39.00K 10-K · filed 2023-02-28 | |
| 2021-03-31 | $39.00K 10-Q · filed 2022-11-02 | $329.70M derived: sum of 4 quarters · filed 2022-11-02 |
| 2020-12-31 | $250.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $329.66M 10-K · filed 2022-02-28 |
| 2020-09-30 | $10.42M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $69.08M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $65.93M 10-K · filed 2021-03-11 |
| 2019-09-30 | $65.93M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |